Medscape Medical NewsAll articles

Steth IO

STRATOSCIENTIFIC, INC. • Cardiovascular • 07/15/2016

510(k)IEC 62304 Class C
FDA Summary PDF

Device Purpose

The Steth IO is an acoustic medical device that integrates with a smartphone, utilizing an acoustic waveguide to channel heart and lung sounds to the phone's microphone for real-time audio output, phonocardiogram visualization, and data recording. It serves as a diagnostic aid for healthcare providers to detect, amplify, and analyze physiological sounds in adult patients during physical assessments in various medical settings.

Summary

The Steth IO Model 1.0 is an acoustic medical device designed to integrate with a smartphone to facilitate the collection and analysis of heart and lung sounds. It functions by attaching to the back of a smartphone, employing an acoustic waveguide to direct sound from its chest piece to the smartphone’s microphone, while concurrently serving as a protective case for the phone. An accompanying smartphone application enables real-time sound analysis, allowing clinicians to listen to auscultated sounds via headphones and visualize them as an on-screen phonocardiogram. This device is intended for use by healthcare providers as a diagnostic aid during physical assessments of adult patients in environments such as hospitals, clinics, and physician offices. It aids in the detection and amplification of physiological sounds within selective frequency ranges, with capabilities to record both the audio and phonocardiogram data for later review or consultation. Key features include its reliance on the smartphone for power, processing, display, and data storage, offering longer recording times and direct on-device visualization compared to some traditional electronic stethoscopes. Its primary contraindication is use on open skin lesions at the examination site.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

StethoscopePhonocardiogramSmartphoneAcoustic deviceHeart soundsLung soundsDiagnostic aidReal-time analysisAcoustic waveguideMedical software

Device Metadata

Submission Number
K160016
Company
STRATOSCIENTIFIC, INC.
Panel
Cardiovascular
Product Code
N/A
Data Type
Signals
Clinical Function
Assessment
AI Function
Analysis
AI Subclass
quantification/feature localization

Relevant Clinical Questions

  • Q1. How does the acoustic performance of the Steth IO's fiberglass/epoxy diaphragm compare to traditional materials or the predicate's polyurethane-coated silicone in terms of sound fidelity and frequency response for cardiac and pulmonary auscultation?; What validation studies were conducted to ensure the real-time analysis and phonocardiogram visualization on the smartphone app accurately represent physiological sounds without introducing artifacts or misinterpretations?; Considering the reliance on a smartphone's microphone, what measures are in place to ensure consistent sound quality and calibration across different smartphone units or if the microphone degrades over time?; How does the Steth IO system address potential cybersecurity risks and ensure patient data privacy when phonocardiogram data is captured, stored, and potentially transmitted using a commercial smartphone platform?; What is the impact of the smartphone's processing power, operating system version, and concurrent background applications on the Steth IO application's performance, particularly concerning real-time analysis accuracy and the potential for software-induced diagnostic delays or errors?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class C (software safety classification); Authorized before §524B enforcement

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score35/100
SBOM Evidence⚠ Not mentioned in summary
Cyber Risk Assessment✓ Detected in Summary
Postmarket Plan⚠ Not mentioned in summary
§524B ApplicableNo

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials
- Not detected
SaaSBOMSoftware-as-a-Service Bill of Materials(platform)
✓ Detected
HBOMHardware Bill of Materials(on-device)
✓ Detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials(environment)
✓ Detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of SaaSBOM, HBOM, OBOM detected in AI-generated device summary.

• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, ML-BOM, CBOM, VDR/VEX. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
Steth IO - STRATOSCIENTIFIC, INC. | ESL FDA AI Device Intelligence